Treatment patterns and prognosis of patients with inoperable stage III NSCLC after completion of concurrent chemoradiotherapy ± immune checkpoint inhibition: a decade-long single-c...

por Flörsch, Benedikt, Taugner, Julian, Käsmann, Lukas, Kenndoff, Saskia, Guggenberger, Julian, Tufman, Amanda, Reinmuth, Niels, Duell, Thomas, Belka, Claus, Eze, Chukwuka, Manapov, Farkhad
Publicado 2022

Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequen...

por Taugner, Julian, Käsmann, Lukas, Karin, Monika, Eze, Chukwuka, Flörsch, Benedikt, Guggenberger, Julian, Li, Minglun, Tufman, Amanda, Reinmuth, Niels, Duell, Thomas, Belka, Claus, Manapov, Farkhad
Publicado 2021

 Concurrent/sequential versus sequential immune checkpoint inhibition in inoperable large stage III non-small cell lung cancer patients treated with chemoradiotherapy: a prospectiv...

por Käsmann, Lukas, Eze, Chukwuka, Taugner, Julian, Nieto, Alexander, Hofstetter, Kerstin, Kröninger, Sophie, Guggenberger, Julian, Kenndoff, Saskia, Flörsch, Benedikt, Tufman, Amanda, Reinmuth, Niels, Duell, Thomas, Belka, Claus, Manapov, Farkhad
Publicado 2023

Prospective evaluation of immunological, molecular-genetic, image-based and microbial analyses to characterize tumor response and control in patients with unresectable stage III NS...

por Käsmann, Lukas, Taugner, Julian, Eze, Chukwuka, Nieto, Alexander, Pelikan, Carolyn, Flörsch, Benedikt, Kenndoff, Saskia, Hofer, Thomas P., Nössner, Elfriede, Schulz, Christian, Unterrainer, Marcus, Tufman, Amanda, Klauschen, Frederick, Jung, Andreas, Neumann, Jens, Kumbrink, Jörg, Reinmuth, Niels, Bartenstein, Peter, Belka, Claus, Manapov, Farkhad
Publicado 2022